time Book a service Book in repairs I'm not sure
For use by persons 18 years of age and older
Possible serious side effects include low blood sugar (hypoglycemia), pancreatitis, kidney failure, and thyroid tumors
The FDA has introduced a "Green List" for IA 66-80, focusing on the "Detention Without Physical Examination of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Bulk Drug Substances." This initiative aims to safeguard against the illegal importation of GLP-1 drug ingredients
You can learn more about this approach in Why Bioavailability Matters
Maharjan R, Lim DS, Baik HJ, Park HE, Kim MS, Kim KH, et al